Answers are grounded in this paper and cite their sources.
Sequential carboplatin/etoposide-based high-dose chemotherapy with stem cell support is a standard therapy option for relapsed germ cell tumors, resulting in cure for approximately 50% of patients. In a recent single-center phase II study, results were reported for a novel combination including gemcitabine, melphalan, docetaxel, and carboplatin. See related article by Nieto et al., p. 300.
No takes yet. Share an insight, caveat, or question.
Kollmannsberger et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: